The city of Memphis, Tennessee, currently has 3 active clinical trials seeking participants for Migraine research studies.
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
NCT04743141
Recruiting
The purpose of this study is to test the long-term safety of rimegepant in the acute treatment of moderate or severe migraine in children and adolescents (≥ 6 to < 18 years of age).
Gender:
All
Ages:
Between 6 years and 17 years
Trial Updated:
05/31/2024
Locations: Le Bonheur Children's Hospital, Memphis, Tennessee +2 locations
Conditions: Acute Treatment of Migraine
Register for Updates
Responding With Evidence and Access for Childhood Headaches
NCT05889624
Recruiting
This comparative effectiveness study will clarify current first-line preventive treatment approaches for use by neurologists, psychologists, and primary care providers in the context of real world care, and will demonstrate the feasibility of Cognitive Behavioral Therapy (CBT) via telehealth for youth with migraine. The focus is on applying evidence-based care and enhancing access to it. CBT via telehealth while taking a clinically-prescribed, pill-based prevention therapy (amitriptyline) will b... Read More
Gender:
All
Ages:
Between 10 years and 17 years
Trial Updated:
05/13/2024
Locations: University of Tennessee Health Science Center/ LeBonheur Children's Hospital, Memphis, Tennessee
Conditions: Headache, Headache Disorders, Headache, Migraine, Migraine, Migraine Disorders, Migraine With Aura, Migraine Without Aura, Chronic Migraine
Register for Updates
Therapy for Migraine Prevention in Children 6-11 Years of Age
NCT04050293
Recruiting
The aim of this study is to evaluate the effect of SPN-538 for the prophylaxis of migraine in pediatric patients 6 to 11 years old.
Gender:
All
Ages:
Between 6 years and 11 years
Trial Updated:
04/23/2024
Locations: CNS Healthcare, Memphis, Tennessee
Conditions: Migraine Disorders, Headache Disorders
Register for Updates